Hologic hits 52-week high on mammography study | Wall Street Beat
Shares of Hologic hit a 52-week high yesterday on a study showing the benefits of mammography using its Selenia 3D device.
HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.
The Norwegian study, published in the journal Radiology , reviewed the results of 12,631 mammograms and found a 27% increase in detection rates for mammograms using 3D tomosynthesis technology. False-positive rates fell 15% and 25 additional invasive cancers were detected using the 3D technology, for a 40% boost.